SK79698A3 - Implantable acrylamide copolymer hydrogel for therapeutic uses - Google Patents

Implantable acrylamide copolymer hydrogel for therapeutic uses Download PDF

Info

Publication number: SK79698A3
Authority: SK; Slovakia
Prior art keywords: polymer; tissue; hydrogel; cells; solution
Prior art date: 1996-10-16

Application number

SK796-98A

Other languages

English (en)

Slovak (sk)

Inventor

Stephane Woerly

Original Assignee

Organogel Canada Ltee

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-16

Filing date

1997-10-15

Publication date

1999-01-11

1997-10-15 Application filed by Organogel Canada Ltee filed Critical Organogel Canada Ltee

1999-01-11 Publication of SK79698A3 publication Critical patent/SK79698A3/sk

Links

239000000017 hydrogel Substances 0.000 title claims abstract description 95
230000001225 therapeutic effect Effects 0.000 title claims description 10
229920006322 acrylamide copolymer Polymers 0.000 title description 2
229920000642 polymer Polymers 0.000 claims abstract description 87
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 11
-1 N-substituted methacrylamide Chemical class 0.000 claims abstract description 11
239000003431 cross linking reagent Substances 0.000 claims abstract description 9
208000031737 Tissue Adhesions Diseases 0.000 claims abstract description 8
235000021310 complex sugar Nutrition 0.000 claims abstract description 8
229920001577 copolymer Polymers 0.000 claims abstract description 8
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
238000000034 method Methods 0.000 claims description 61
239000000499 gel Substances 0.000 claims description 33
239000000463 material Substances 0.000 claims description 29
210000000278 spinal cord Anatomy 0.000 claims description 22
239000011148 porous material Substances 0.000 claims description 20
239000000203 mixture Substances 0.000 claims description 19
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 12
239000002243 precursor Substances 0.000 claims description 10
210000005013 brain tissue Anatomy 0.000 claims description 9
239000002904 solvent Substances 0.000 claims description 9
230000015572 biosynthetic process Effects 0.000 claims description 7
230000001537 neural effect Effects 0.000 claims description 7
238000006116 polymerization reaction Methods 0.000 claims description 7
230000008569 process Effects 0.000 claims description 7
235000000346 sugar Nutrition 0.000 claims description 7
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 6
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 6
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 6
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 6
239000002253 acid Substances 0.000 claims description 6
230000003376 axonal effect Effects 0.000 claims description 6
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 6
229960002442 glucosamine Drugs 0.000 claims description 6
150000002632 lipids Chemical class 0.000 claims description 6
229950006780 n-acetylglucosamine Drugs 0.000 claims description 6
239000002245 particle Substances 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 5
ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 5
210000001328 optic nerve Anatomy 0.000 claims description 5
210000003169 central nervous system Anatomy 0.000 claims description 4
238000004132 cross linking Methods 0.000 claims description 4
239000003999 initiator Substances 0.000 claims description 4
208000014674 injury Diseases 0.000 claims description 4
210000000578 peripheral nerve Anatomy 0.000 claims description 4
239000007870 radical polymerization initiator Substances 0.000 claims description 4
231100000241 scar Toxicity 0.000 claims description 4
150000003926 acrylamides Chemical class 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 3
235000010323 ascorbic acid Nutrition 0.000 claims description 3
229960005070 ascorbic acid Drugs 0.000 claims description 3
239000011668 ascorbic acid Substances 0.000 claims description 3
230000002950 deficient Effects 0.000 claims description 3
241001465754 Metazoa Species 0.000 claims description 2
125000004432 carbon atom Chemical group C* 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims description 2
125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
229940127121 immunoconjugate Drugs 0.000 claims description 2
FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
230000037361 pathway Effects 0.000 claims description 2
150000002978 peroxides Chemical class 0.000 claims description 2
BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical class OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 claims 2
208000032544 Cicatrix Diseases 0.000 claims 1
241000124008 Mammalia Species 0.000 claims 1
KBGAYAKRZNYFFG-BOHATCBPSA-N aceneuramic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](NC(=O)C)[C@@H](O)[C@H](O)[C@H](O)CO KBGAYAKRZNYFFG-BOHATCBPSA-N 0.000 claims 1
230000000694 effects Effects 0.000 claims 1
239000003505 polymerization initiator Substances 0.000 claims 1
229920001282 polysaccharide Polymers 0.000 claims 1
230000037387 scars Effects 0.000 claims 1
239000003106 tissue adhesive Substances 0.000 claims 1
230000008736 traumatic injury Effects 0.000 claims 1
210000000056 organ Anatomy 0.000 abstract description 26
230000017423 tissue regeneration Effects 0.000 abstract description 13
210000000653 nervous system Anatomy 0.000 abstract description 6
230000008439 repair process Effects 0.000 abstract description 5
210000004027 cell Anatomy 0.000 description 103
210000001519 tissue Anatomy 0.000 description 80
239000011159 matrix material Substances 0.000 description 26
238000002360 preparation method Methods 0.000 description 19
210000004556 brain Anatomy 0.000 description 15
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
239000000243 solution Substances 0.000 description 11
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
238000002513 implantation Methods 0.000 description 10
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
239000007943 implant Substances 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
239000000047 product Substances 0.000 description 8
239000012981 Hank's balanced salt solution Substances 0.000 description 7
210000000944 nerve tissue Anatomy 0.000 description 7
238000002054 transplantation Methods 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
208000020431 spinal cord injury Diseases 0.000 description 6
239000002028 Biomass Substances 0.000 description 5
108010035532 Collagen Proteins 0.000 description 5
102000008186 Collagen Human genes 0.000 description 5
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 5
241000700159 Rattus Species 0.000 description 5
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 5
210000001130 astrocyte Anatomy 0.000 description 5
210000003050 axon Anatomy 0.000 description 5
229920001436 collagen Polymers 0.000 description 5
230000006378 damage Effects 0.000 description 5
230000012010 growth Effects 0.000 description 5
239000003102 growth factor Substances 0.000 description 5
210000002569 neuron Anatomy 0.000 description 5
229910052757 nitrogen Inorganic materials 0.000 description 5
208000027418 Wounds and injury Diseases 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000007547 defect Effects 0.000 description 4
230000006870 function Effects 0.000 description 4
239000000178 monomer Substances 0.000 description 4
210000005036 nerve Anatomy 0.000 description 4
230000008929 regeneration Effects 0.000 description 4
238000011069 regeneration method Methods 0.000 description 4
239000000758 substrate Substances 0.000 description 4
VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 3
208000012868 Overgrowth Diseases 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000008614 cellular interaction Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
210000003722 extracellular fluid Anatomy 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000035876 healing Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000002372 labelling Methods 0.000 description 3
230000003902 lesion Effects 0.000 description 3
239000007788 liquid Substances 0.000 description 3
230000007774 longterm Effects 0.000 description 3
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
229910052753 mercury Inorganic materials 0.000 description 3
210000002220 organoid Anatomy 0.000 description 3
230000035699 permeability Effects 0.000 description 3
229920002959 polymer blend Polymers 0.000 description 3
210000004116 schwann cell Anatomy 0.000 description 3
239000000126 substance Substances 0.000 description 3
230000008961 swelling Effects 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
206010010356 Congenital anomaly Diseases 0.000 description 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
102000016359 Fibronectins Human genes 0.000 description 2
108010067306 Fibronectins Proteins 0.000 description 2
108010085895 Laminin Proteins 0.000 description 2
102000007547 Laminin Human genes 0.000 description 2
108010038807 Oligopeptides Proteins 0.000 description 2
102000015636 Oligopeptides Human genes 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
206010052428 Wound Diseases 0.000 description 2
ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 2
229910001870 ammonium persulfate Inorganic materials 0.000 description 2
238000013459 approach Methods 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
239000000227 bioadhesive Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
239000012620 biological material Substances 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
229940112869 bone morphogenetic protein Drugs 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
210000001612 chondrocyte Anatomy 0.000 description 2
238000007334 copolymerization reaction Methods 0.000 description 2
239000002577 cryoprotective agent Substances 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
239000000835 fiber Substances 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
230000008595 infiltration Effects 0.000 description 2
238000001764 infiltration Methods 0.000 description 2
QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
230000036244 malformation Effects 0.000 description 2
239000002609 medium Substances 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
230000008520 organization Effects 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229920001562 poly(N-(2-hydroxypropyl)methacrylamide) Polymers 0.000 description 2
230000000379 polymerizing effect Effects 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000007634 remodeling Methods 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
239000002356 single layer Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
210000000130 stem cell Anatomy 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
230000025366 tissue development Effects 0.000 description 2
239000011800 void material Substances 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
XQQUSYWGKLRJRA-RABCQHRBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-methylbutanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XQQUSYWGKLRJRA-RABCQHRBSA-N 0.000 description 1
MWOGMBZGFFZBMK-LJZWMIMPSA-N (2s)-2-[[(2s)-2-[[2-[[(2s,3s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWOGMBZGFFZBMK-LJZWMIMPSA-N 0.000 description 1
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
JVJUWEFOGFCHKR-UHFFFAOYSA-N 2-(diethylamino)ethyl 1-(3,4-dimethylphenyl)cyclopentane-1-carboxylate;hydrochloride Chemical class Cl.C=1C=C(C)C(C)=CC=1C1(C(=O)OCCN(CC)CC)CCCC1 JVJUWEFOGFCHKR-UHFFFAOYSA-N 0.000 description 1
XXJWUZQJPJLUNE-UHFFFAOYSA-N 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl 3-methylbut-2-enoate Chemical compound CC(=CC(=O)OCCOCCOCCOCCO)C XXJWUZQJPJLUNE-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
LXDQROPOJYHQLE-OXNFMAJFSA-N 2-methyl-n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]prop-2-enamide Chemical compound CC(=C)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O LXDQROPOJYHQLE-OXNFMAJFSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
206010051290 Central nervous system lesion Diseases 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
206010061431 Glial scar Diseases 0.000 description 1
206010018341 Gliosis Diseases 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
229920001612 Hydroxyethyl starch Polymers 0.000 description 1
238000004566 IR spectroscopy Methods 0.000 description 1
101710167839 Morphogenetic protein Proteins 0.000 description 1
KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
102000010803 Netrins Human genes 0.000 description 1
108010063605 Netrins Proteins 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
206010053159 Organ failure Diseases 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
102000014105 Semaphorin Human genes 0.000 description 1
108050003978 Semaphorin Proteins 0.000 description 1
229920001963 Synthetic biodegradable polymer Polymers 0.000 description 1
229940008309 acetone / ethanol Drugs 0.000 description 1
230000009471 action Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000002502 anti-myelin effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000002902 bimodal effect Effects 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
239000003181 biological factor Substances 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
244000309464 bull Species 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
230000011712 cell development Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000003710 cerebral cortex Anatomy 0.000 description 1
210000004298 cerebral vein Anatomy 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
GRFFKYTUNTWAGG-UHFFFAOYSA-N chloroethene;prop-2-enenitrile Chemical compound ClC=C.C=CC#N GRFFKYTUNTWAGG-UHFFFAOYSA-N 0.000 description 1
239000000501 collagen implant Substances 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
229920000547 conjugated polymer Polymers 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000037029 cross reaction Effects 0.000 description 1
239000013078 crystal Substances 0.000 description 1
UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
239000004062 cytokinin Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
229920006237 degradable polymer Polymers 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
238000009826 distribution Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000003328 fibroblastic effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000007849 functional defect Effects 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000000025 haemostatic effect Effects 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
229940050526 hydroxyethylstarch Drugs 0.000 description 1
238000007654 immersion Methods 0.000 description 1
210000001822 immobilized cell Anatomy 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000012151 immunohistochemical method Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
108010088381 isoleucyl-lysyl-valyl-alanyl-valine Proteins 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
108010082117 matrigel Proteins 0.000 description 1
230000035800 maturation Effects 0.000 description 1
230000006386 memory function Effects 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
OKPYIWASQZGASP-UHFFFAOYSA-N n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(O)CNC(=O)C(C)=C OKPYIWASQZGASP-UHFFFAOYSA-N 0.000 description 1
ZTUGCJNAJJDKDC-UHFFFAOYSA-N n-(3-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCCCO ZTUGCJNAJJDKDC-UHFFFAOYSA-N 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
210000001577 neostriatum Anatomy 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
239000012071 phase Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920001432 poly(L-lactide) Polymers 0.000 description 1
229920002187 poly[N-2-(hydroxypropyl) methacrylamide] polymer Polymers 0.000 description 1
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
229920005597 polymer membrane Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000002459 porosimetry Methods 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000012673 precipitation polymerization Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000012966 redox initiator Substances 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000008521 reorganization Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000004626 scanning electron microscopy Methods 0.000 description 1
230000036573 scar formation Effects 0.000 description 1
239000000565 sealant Substances 0.000 description 1
210000001044 sensory neuron Anatomy 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
229940001584 sodium metabisulfite Drugs 0.000 description 1
235000010262 sodium metabisulphite Nutrition 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000009331 sowing Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
238000004381 surface treatment Methods 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
229920001897 terpolymer Polymers 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
230000025934 tissue morphogenesis Effects 0.000 description 1
230000007838 tissue remodeling Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
108010052768 tyrosyl-isoleucyl-glycyl-seryl-arginine Proteins 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Zoology (AREA)
Botany (AREA)
Cell Biology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Processes Of Treating Macromolecular Substances (AREA)
Medicinal Preparation (AREA)
Compositions Of Macromolecular Compounds (AREA)
Peptides Or Proteins (AREA)

SK796-98A 1996-10-16 1997-10-15 Implantable acrylamide copolymer hydrogel for therapeutic uses SK79698A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/731,484 US5863551A (en)	1996-10-16	1996-10-16	Implantable polymer hydrogel for therapeutic uses
PCT/CA1997/000766 WO1998016266A1 (en)	1996-10-16	1997-10-15	Implantable acrylamide copolymer hydrogel for therapeutic uses

Publications (1)

Publication Number	Publication Date
SK79698A3 true SK79698A3 (en)	1999-01-11

Family

ID=24939700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK796-98A SK79698A3 (en)	1996-10-16	1997-10-15	Implantable acrylamide copolymer hydrogel for therapeutic uses

Country Status (18)

Country	Link
US (1)	US5863551A (cs)
EP (1)	EP0929323B1 (cs)
JP (1)	JP3542810B2 (cs)
KR (1)	KR100377520B1 (cs)
CN (1)	CN1211194A (cs)
AT (1)	ATE284717T1 (cs)
AU (1)	AU744666B2 (cs)
BR (1)	BR9706835A (cs)
CA (1)	CA2240721C (cs)
CZ (1)	CZ187698A3 (cs)
DE (1)	DE69731959T2 (cs)
HU (1)	HUP9902027A3 (cs)
IL (1)	IL124894A (cs)
NZ (1)	NZ330664A (cs)
PL (1)	PL327454A1 (cs)
RU (1)	RU2198686C2 (cs)
SK (1)	SK79698A3 (cs)
WO (1)	WO1998016266A1 (cs)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4335316B2 (ja) *	1996-09-19	2009-09-30	ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン	アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
US8003705B2 (en) *	1996-09-23	2011-08-23	Incept Llc	Biocompatible hydrogels made with small molecule precursors
US20030008396A1 (en) *	1999-03-17	2003-01-09	Ku David N.	Poly(vinyl alcohol) hydrogel
WO1999060938A1 (en)	1998-05-23	1999-12-02	Focal, Inc.	Method of treatment for premature rupture of membranes in pregnancy (prom)
US6165193A (en)	1998-07-06	2000-12-26	Microvention, Inc.	Vascular embolization with an expansible implant
US6464850B1 (en)	1998-07-31	2002-10-15	Biowhittaker Molecular Applications, Inc.	Method for producing hydrophilic monomers and uses thereof
US6117293A (en) *	1998-07-31	2000-09-12	Biowhittaker Molecular Applications, Inc.	Method for producing hydrophilic monomers and uses thereof
US6818018B1 (en)	1998-08-14	2004-11-16	Incept Llc	In situ polymerizable hydrogels
EP1137373A4 (en) *	1998-12-04	2004-05-19	Chandrashekhar P Pathak	BIOCOMPATIBLE, CROSSLINKED POLYMERS
US6511650B1 (en) *	1999-04-09	2003-01-28	The Regents Of The University Of Michigan	Preparing porous hydrogel products
US6264695B1 (en) *	1999-09-30	2001-07-24	Replication Medical, Inc.	Spinal nucleus implant
CA2394077A1 (en) *	1999-12-16	2001-06-21	Trident Technologies, Llc	System and method for extended delivery of a therapeutic agent with its receptor loading dose
US6664305B2 (en)	2000-06-27	2003-12-16	Bia Separations D.O.O.	Chromatography material and a process of manufacturing that material
US8366787B2 (en) *	2000-08-04	2013-02-05	Depuy Products, Inc.	Hybrid biologic-synthetic bioabsorbable scaffolds
US6638312B2 (en) *	2000-08-04	2003-10-28	Depuy Orthopaedics, Inc.	Reinforced small intestinal submucosa (SIS)
US7204851B2 (en) *	2000-08-30	2007-04-17	Sdgi Holdings, Inc.	Method and apparatus for delivering an intervertebral disc implant
EP1563808B1 (en)	2000-08-30	2008-04-02	Warsaw Orthopedic, Inc.	Intervertebral disc nucleus implants
US7503936B2 (en) *	2000-08-30	2009-03-17	Warsaw Orthopedic, Inc.	Methods for forming and retaining intervertebral disc implants
US20020026244A1 (en) *	2000-08-30	2002-02-28	Trieu Hai H.	Intervertebral disc nucleus implants and methods
US6620196B1 (en)	2000-08-30	2003-09-16	Sdgi Holdings, Inc.	Intervertebral disc nucleus implants and methods
US6878384B2 (en)	2001-03-13	2005-04-12	Microvention, Inc.	Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
KR100444944B1 (ko) *	2001-05-24	2004-08-18	선바이오(주)	생체 접착제용 폴리에틸렌글리콜 수화젤
US20030032961A1 (en) *	2001-07-16	2003-02-13	Pelo Mark Joseph	Devices from naturally occurring biologically derived materials
US7201917B2 (en)	2001-07-16	2007-04-10	Depuy Products, Inc.	Porous delivery scaffold and method
JP4197157B2 (ja) *	2001-07-16	2008-12-17	デピュイ・プロダクツ・インコーポレイテッド	軟骨修復再生装置および方法
US8025896B2 (en) *	2001-07-16	2011-09-27	Depuy Products, Inc.	Porous extracellular matrix scaffold and method
AU2002316694B2 (en)	2001-07-16	2007-09-06	Depuy Products, Inc.	Hybrid biologic/synthetic porous extracellular matrix scaffolds
JP4302515B2 (ja) *	2001-07-16	2009-07-29	デピュイ・プロダクツ・インコーポレイテッド	単体型外科装置および方法
US8092529B2 (en) *	2001-07-16	2012-01-10	Depuy Products, Inc.	Meniscus regeneration device
US7819918B2 (en) *	2001-07-16	2010-10-26	Depuy Products, Inc.	Implantable tissue repair device
MXPA04002967A (es) *	2001-09-28	2004-07-15	Biopharma Dev Ltd	Hidrogel biocompatible polifuncional y metodo para la produccion del mismo.
US20040047843A1 (en) *	2002-02-12	2004-03-11	Uab Research Foundation	Method for spinal cord reconnection
US20030229333A1 (en) *	2002-02-22	2003-12-11	Control Delivery Systems, Inc.	Methods for treating otic disorders
EP1482994A1 (en) *	2002-03-11	2004-12-08	First Water Limited	Absorbent hydrogels
KR100675459B1 (ko) *	2002-04-10	2007-01-26	오브스체스트보 에스 오그라니체노이 오트베트스트벤노스츄 (비타겔)	다관능 생체적합 친수성 젤 및 그 제조방법
JP2005530768A (ja) *	2002-05-09	2005-10-13	メディジーンズ	血漿または血清を含有した創傷治療用医薬組成物
US20040166169A1 (en) *	2002-07-15	2004-08-26	Prasanna Malaviya	Porous extracellular matrix scaffold and method
AU2003254677A1 (en) *	2002-08-09	2004-02-25	Ottawa Health Research Institute	Innervated artificial tissues and uses thereof
US7569222B2 (en) *	2002-11-18	2009-08-04	Woerly Stephane	Hydrogel membrane composition and use thereof
AU2003303206A1 (en) *	2002-12-18	2004-07-14	The Regents Of The University Of California	Biocompatible hydrogel bone-like composites
WO2004071336A2 (en) *	2003-02-06	2004-08-26	The General Hospital Corporation D/B/A Massachusetts General Hospital	Hydrophilic fibrous capsule resistant prosthetic device
US7785769B2 (en) *	2003-07-25	2010-08-31	The United States of America as reprsented by the Secretary of the Navy	Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
EP1729678A4 (en) *	2004-02-06	2011-08-10	Georgia Tech Res Inst	LOAD-WEARING BIO-COMPATIBLE DEVICE
WO2005077013A2 (en)	2004-02-06	2005-08-25	Georgia Tech Research Corporation	Surface directed cellular attachment
US20050249772A1 (en) *	2004-05-04	2005-11-10	Prasanna Malaviya	Hybrid biologic-synthetic bioabsorbable scaffolds
US7569233B2 (en) *	2004-05-04	2009-08-04	Depuy Products, Inc.	Hybrid biologic-synthetic bioabsorbable scaffolds
US20050278025A1 (en) *	2004-06-10	2005-12-15	Salumedica Llc	Meniscus prosthesis
US7303074B2 (en) *	2004-09-22	2007-12-04	Dombrowski Trudy M	Foldable organizer device
US20070142326A1 (en) *	2004-09-30	2007-06-21	Youe-Kong Shue	Treatment of a condition in a mammal with administration of aminosugar and uses thereof
US20060089719A1 (en) *	2004-10-21	2006-04-27	Trieu Hai H	In situ formation of intervertebral disc implants
US7313829B1 (en) *	2004-10-29	2008-01-01	Payload Systems, Inc.	Sealing device for body suit and sealing method using hydrogels
US7513866B2 (en) *	2004-10-29	2009-04-07	Depuy Products, Inc.	Intestine processing device and associated method
RU2290939C2 (ru) *	2004-12-14	2007-01-10	Государственное образовательное учреждение высшего профессионального образования Новосибирская государственная медицинская академия Министерства здравоохранения Российской Федерации	Средство для лечения повреждений спинного и головного мозга
US7354627B2 (en) *	2004-12-22	2008-04-08	Depuy Products, Inc.	Method for organizing the assembly of collagen fibers and compositions formed therefrom
US7595062B2 (en)	2005-07-28	2009-09-29	Depuy Products, Inc.	Joint resurfacing orthopaedic implant and associated method
BRPI0615391A2 (pt) *	2005-08-26	2011-05-17	Synthes Gmbh	prótese para substituir ou suplementar um núcleo pulposo de um disco intervertebral
US8383415B2 (en) *	2005-10-13	2013-02-26	Dso National Laboratories	Hydrogel composition to enhance fluorescence
WO2007070660A2 (en)	2005-12-13	2007-06-21	President And Fellows Of Harvard College	Scaffolds for cell transplantation
DE602007008692D1 (de) *	2006-03-03	2010-10-07	Akzo Nobel Nv	Verfahren zur modifizierung biologisch abbaubarer polymere
US8377091B2 (en)	2006-06-15	2013-02-19	Microvention, Inc.	Embolization device constructed from expansile polymer
US8066750B2 (en)	2006-10-06	2011-11-29	Warsaw Orthopedic, Inc	Port structures for non-rigid bone plates
US7871440B2 (en) *	2006-12-11	2011-01-18	Depuy Products, Inc.	Unitary surgical device and method
EP2149581A4 (en) *	2007-04-20	2010-04-14	Uchrezhdenie Rossiiskoi Akadem	MONOMER AND COMPOSITION FOR PREPARING A LOW-PROPER HYDROGEL AND / OR A HYDROGEL WITH A LOW CROSS-LINKING CONTENT, HYDROGEL, AND BIOCHIP BASED THEREFROM
WO2008130068A1 (en) *	2007-04-23	2008-10-30	Modern Cell & Tissue Technologies Inc.	Method for preparing a porous polymer scaffold using dry ice
US8067028B2 (en) *	2007-08-13	2011-11-29	Confluent Surgical Inc.	Drug delivery device
CN101903051B (zh)	2007-12-21	2013-07-31	微温森公司	用于生物医药用途的水凝胶细丝
CA2715460C (en)	2008-02-13	2020-02-18	President And Fellows Of Harvard College	Continuous cell programming devices
WO2009108760A2 (en)	2008-02-26	2009-09-03	Board Of Regents, The University Of Texas System	Dendritic macroporous hydrogels prepared by crystal templating
US8586086B2 (en)	2008-05-29	2013-11-19	Politecnico Di Milano	Hydrogel capable of containing and conveying cells
US20120009242A1 (en) *	2008-11-03	2012-01-12	University Of Maryland, College Park	Blood coagulation inducing polymer hydrogel
FR2942408B1 (fr)	2009-02-24	2012-01-27	Stephane Woerly	Hydrogel heterogene hybride et son utilisation therapeutique
BRPI1014645B1 (pt)	2009-04-30	2020-07-07	Technip France	método e sistema para compartilhar linhas de amarração
US10639396B2 (en)	2015-06-11	2020-05-05	Microvention, Inc.	Polymers
FR2945293B1 (fr) *	2009-05-11	2011-06-17	Teoxane	Procede de preparation d'un gel reticule.
CN102791183B (zh)	2009-10-26	2015-07-08	微排放器公司	由可膨胀的聚合物构成的栓塞装置
HRP20200310T1 (hr)	2010-10-06	2020-08-21	President And Fellows Of Harvard College	Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
US9095558B2 (en)	2010-10-08	2015-08-04	Board Of Regents, The University Of Texas System	Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
US8946194B2 (en)	2010-10-08	2015-02-03	Board Of Regents, University Of Texas System	One-step processing of hydrogels for mechanically robust and chemically desired features
EP2629780A4 (en)	2010-10-20	2014-10-01	206 Ortho Inc	IMPLANTABLE POLYMER FOR BONE AND VASCULAR LESIONS
US11484627B2 (en)	2010-10-20	2022-11-01	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US10525169B2 (en)	2010-10-20	2020-01-07	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US11291483B2 (en)	2010-10-20	2022-04-05	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
US11207109B2 (en)	2010-10-20	2021-12-28	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US10525168B2 (en)	2010-10-20	2020-01-07	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
US11058796B2 (en)	2010-10-20	2021-07-13	206 Ortho, Inc.	Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
WO2012145431A2 (en)	2011-04-18	2012-10-26	Microvention, Inc.	Embolic devices
ES2685327T3 (es) *	2011-04-28	2018-10-08	President And Fellows Of Harvard College	Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
US9675561B2 (en)	2011-04-28	2017-06-13	President And Fellows Of Harvard College	Injectable cryogel vaccine devices and methods of use thereof
CA3048443C (en)	2011-05-26	2021-01-05	Cartiva, Inc.	Tapered joint implant and related tools
US9486512B2 (en)	2011-06-03	2016-11-08	President And Fellows Of Harvard College	In situ antigen-generating cancer vaccine
RU2521194C2 (ru) *	2011-11-16	2014-06-27	Общество с ограниченной ответственностью предприятие "Репер"	Матрица для клеточной трансплантологии
EP2819620A4 (en)	2012-02-29	2015-11-04	206 Ortho Inc	METHOD AND APPARATUS FOR TREATING BONE FRACTURES, INCLUDING THE USE OF COMPOSITE IMPLANTS
CN102600067B (zh) *	2012-04-10	2013-08-21	武汉大学	含氨基葡萄糖单元的糖肽水凝胶的制备方法及其在制备术后疤痕抑制剂上的应用
ES2773895T3 (es)	2012-04-16	2020-07-15	Harvard College	Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
DE102012019984A1 (de) *	2012-10-11	2014-04-17	Leibniz-Institut für Oberflächenmodifizierung e.V.	Verfahren zur Herstellung von porösen Gelen mit inkorporierten katalytisch oder biologisch aktiven Materialien sowie damit hergestellte Gele und deren Verwendung
BR112015013774A2 (pt)	2012-12-11	2017-07-11	Univ Texas	membrana de hidrogel para prevenção de adesão
US11565027B2 (en)	2012-12-11	2023-01-31	Board Of Regents, The University Of Texas System	Hydrogel membrane for adhesion prevention
EP3795635A1 (en)	2013-05-23	2021-03-24	206 ORTHO, Inc.	Apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
JP6599361B2 (ja)	2014-04-29	2019-10-30	マイクロベンションインコーポレイテッド	活性剤を含むポリマー
CN107073090A (zh)	2014-04-30	2017-08-18	哈佛学院董事会	结合的疫苗装置和杀死癌细胞的方法
WO2015200905A2 (en)	2014-06-28	2015-12-30	Oligasis, Llc	Dual pdgf/vegf antagonists
US9947242B2 (en) *	2014-07-22	2018-04-17	Synaptive Medical (Barbados) Inc.	Method for producing anatomical phantoms with constituents having variable densities
US10150884B2 (en) *	2014-08-14	2018-12-11	The Secant Group, Llc	Composition, methods and devices useful for manufacturing of implantable articles
WO2016123573A1 (en)	2015-01-30	2016-08-04	President And Fellows Of Harvard College	Peritumoral and intratumoral materials for cancer therapy
EP3277219B1 (en)	2015-03-31	2020-07-29	Cartiva, Inc.	Hydrogel implants with porous materials
EP3892241A1 (en)	2015-03-31	2021-10-13	Cartiva, Inc.	Drill bit for carpometacarpal implant
US11150242B2 (en)	2015-04-10	2021-10-19	President And Fellows Of Harvard College	Immune cell trapping devices and methods for making and using the same
CA2981074C (en)	2015-04-14	2023-03-28	Cartiva, Inc.	Tooling for creating tapered opening in tissue and related methods
RU2594427C1 (ru) *	2015-06-10	2016-08-20	Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН)	Композиция для формирования макропористого носителя, используемого при трехмерном культивировании клеток животных или человека, и способ получения указанного носителя
IL290457B2 (en)	2015-12-30	2025-02-01	Kodiak Sciences Inc	Antibodies and their conjugates
DE102016000458A1 (de) *	2016-01-12	2017-07-27	Friedrich-Schiller-Universität Jena	Poröse Glycopolymer-funktionalisierte Cryogele und deren Verwendung
WO2017136837A1 (en)	2016-02-06	2017-08-10	President And Fellows Of Harvard College	Recapitulating the hematopoietic niche to reconstitute immunity
AU2017295704B2 (en)	2016-07-13	2023-07-13	President And Fellows Of Harvard College	Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
CN110418651A (zh)	2016-08-02	2019-11-05	哈佛学院院长等	用于调节免疫应答的生物材料
US11980700B2 (en)	2017-03-08	2024-05-14	Alafair Biosciences, Inc.	Hydrogel medium for the storage and preservation of tissue
CN107096065B (zh) *	2017-04-05	2019-11-15	浙江大学	含多聚唾液酸复合纳米纤维膜及制备方法和应用
CN108187137A (zh) *	2018-02-27	2018-06-22	崔友军	一种可生物降解神经修复支架的制备方法
CA3092588A1 (en)	2018-03-02	2019-09-06	Kodiak Sciences Inc.	Il-6 antibodies and fusion constructs and conjugates thereof
WO2020061129A1 (en)	2018-09-19	2020-03-26	President And Fellows Of Harvard College	Compositions and methods for labeling and modulation of cells in vitro and in vivo
PL241064B1 (pl)	2018-10-01	2022-08-01	Dolniak Blazej	Sposób wytwarzania lepko-sprężystego żelu uzupełniającego maź stawową i lepko-sprężysty żel uzupełniający maź stawową
JP2022514568A (ja)	2018-12-17	2022-02-14	プレジデントアンドフェローズオブハーバードカレッジ	免疫系のモジュレーションのための生物工学的スキャフォールドおよびその使用
JP2022549270A (ja)	2019-09-23	2022-11-24	プレジデントアンドフェローズオブハーバードカレッジ	バイオマテリアルベースの無抗原ワクチンおよびその使用
CA3157509A1 (en)	2019-10-10	2021-04-15	Kodiak Sciences Inc.	Methods of treating an eye disorder
EP4084802A4 (en) *	2020-01-03	2024-03-13	Repertoire Immune Medicines, Inc.	COMPOSITIONS OF HYDROGELS AND METHODS OF USE THEREOF
FR3108260B1 (fr) *	2020-03-17	2024-01-05	Neurobiomat	Hydrogel hétérogène hybride, procédé de fabrication et utilisation comme implant de comblement non-dégradable in-situ
CN113599566B (zh) *	2021-08-30	2022-10-25	重庆市沙坪坝区中智医谷研究院	一种疏水性高分子止血修复材料、其制备方法及应用
CN113729654B (zh) *	2021-09-14	2023-03-28	华中科技大学	术后皮瓣与重建肢体血流状态检测表皮贴附式传感系统
DE102023131358A1 (de) *	2023-11-09	2025-05-15	INM - Leibniz-Institut für Neue Materialien gemeinnützige Gesellschaft mit beschränkter Haftung	Selbst-schmierende Kontaktlinsen
CN120757703B (zh) *	2025-09-09	2025-12-02	天津大学	一种基于两性离子聚合物的水凝胶睾丸假体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8418772D0 (en) *	1984-07-24	1984-08-30	Geistlich Soehne Ag	Chemical substances
GB8422950D0 (en) *	1984-09-11	1984-10-17	Warne K J	Hydrogel
US4902295A (en) *	1985-08-26	1990-02-20	Hana Biologics, Inc.	Transplantable artificial tissue
US5266325A (en) *	1990-09-28	1993-11-30	Hydro Med Science Division Of National Patent Development Corp.	Preparation of homogeneous hydrogel copolymers

1996
- 1996-10-16 US US08/731,484 patent/US5863551A/en not_active Expired - Lifetime
1997
- 1997-10-15 RU RU98113303/14A patent/RU2198686C2/ru not_active IP Right Cessation
- 1997-10-15 KR KR10-1998-0704544A patent/KR100377520B1/ko not_active Expired - Fee Related
- 1997-10-15 DE DE69731959T patent/DE69731959T2/de not_active Expired - Fee Related
- 1997-10-15 IL IL12489497A patent/IL124894A/en not_active IP Right Cessation
- 1997-10-15 WO PCT/CA1997/000766 patent/WO1998016266A1/en not_active Ceased
- 1997-10-15 AU AU46126/97A patent/AU744666B2/en not_active Ceased
- 1997-10-15 CA CA002240721A patent/CA2240721C/en not_active Expired - Lifetime
- 1997-10-15 JP JP51786898A patent/JP3542810B2/ja not_active Expired - Fee Related
- 1997-10-15 AT AT97944663T patent/ATE284717T1/de not_active IP Right Cessation
- 1997-10-15 EP EP97944663A patent/EP0929323B1/en not_active Expired - Lifetime
- 1997-10-15 SK SK796-98A patent/SK79698A3/sk unknown
- 1997-10-15 HU HU9902027A patent/HUP9902027A3/hu unknown
- 1997-10-15 CZ CZ981876A patent/CZ187698A3/cs unknown
- 1997-10-15 BR BR9706835-7A patent/BR9706835A/pt not_active IP Right Cessation
- 1997-10-15 CN CN97191715A patent/CN1211194A/zh active Pending
- 1997-10-15 NZ NZ330664A patent/NZ330664A/en unknown
- 1997-10-15 PL PL97327454A patent/PL327454A1/xx unknown

Also Published As

Publication number	Publication date
ATE284717T1 (de)	2005-01-15
DE69731959D1 (de)	2005-01-20
NZ330664A (en)	1999-10-28
EP0929323B1 (en)	2004-12-15
HUP9902027A3 (en)	2001-04-28
AU744666B2 (en)	2002-02-28
IL124894A0 (en)	1999-01-26
CA2240721A1 (en)	1998-04-23
CA2240721C (en)	2007-01-09
WO1998016266A1 (en)	1998-04-23
KR19990072185A (ko)	1999-09-27
JP2000503884A (ja)	2000-04-04
HUP9902027A2 (hu)	1999-10-28
RU2198686C2 (ru)	2003-02-20
DE69731959T2 (de)	2006-04-13
PL327454A1 (en)	1998-12-07
JP3542810B2 (ja)	2004-07-14
CZ187698A3 (cs)	1998-11-11
IL124894A (en)	2004-06-20
CN1211194A (zh)	1999-03-17
KR100377520B1 (ko)	2003-06-09
AU4612697A (en)	1998-05-11
US5863551A (en)	1999-01-26
BR9706835A (pt)	1999-12-28
EP0929323A1 (en)	1999-07-21

Publication	Publication Date	Title
RU2198686C2 (ru)	2003-02-20	Полимерный гидрогель акриламидного сополимера терапевтического применения и способ его получения
Woerly et al.	1996	Neural tissue engineering: from polymer to biohybrid organs
US7601525B2 (en)	2009-10-13	Alginate gel scaffold having a plurality of continuous parallel microtubular copper capillaries
EP0772466B1 (en)	2003-12-03	Compositions and methods for a bioartificial extracellular matrix
EP0707498B1 (en)	2003-06-25	Implantable prosthesis, kit and device for manufacturing the same
KR20080065973A (ko)	2008-07-15	상호침투성 망상구조, 및 관련 방법 및 조성물
IL205151A (en)	2012-02-29	Use of alginate matrices to control cell growth
Li et al.	2019	Preparation and in vivo investigation of oligomeric proanthocyanidins cross-linked collagen serving as synthesized tissue regeneration membrane
CN108409938A (zh)	2018-08-17	一种新型可降解聚氨酯生物材料及其制备方法和应用
KR102194155B1 (ko)	2020-12-22	온도 감응성 폴리머가 접합된 홍합 접착 단백질을 포함하는 온도 감응성 생체 소재
Giannetti et al.	2001	Acrylic hydrogel implants after spinal cord lesion in the adult rat
KR102493436B1 (ko)	2023-01-31	수축 제어가 가능한 진피층 개발, 및 이를 이용한 균일한 성능의 인공피부 의 제조
Conova et al.	2011	A pilot study of poly (N-isopropylacrylamide)-g-polyethylene glycol and poly (N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord
Chummun et al.	2022	Polysucrose hydrogel and nanofiber scaffolds for skin tissue regeneration: Architecture and cell response
WO2003026489A2 (en)	2003-04-03	Biopolymer and biopolymer-cell compositions for nerve tissue repair
KR20030032420A (ko)	2003-04-26	손상된 안구 조직의 재생을 위한 생분해성 고분자로제조된 다공성 지지체
Woerly et al.	1993	Synthetic polymer matrices for neural cell transplantation
RU2521194C2 (ru)	2014-06-27	Матрица для клеточной трансплантологии
CN100536933C (zh)	2009-09-09	一种接枝蛋白水凝胶生物材料及其制备方法
MXPA98004836A (es)	1999-05-31	Hidrogel de copolimero de acrilamida implantablepara usos terapeuticos
KR100231279B1 (ko)	1999-11-15	치주조직을 복원하기 위한 골아세포 이식용 조직성장인자를 함유한 생분해성 폴리사카라이드 스폰지제제
HK1018942A (en)	2000-01-14	Implantable acrylamide copolymer hydrogel for therapeutic uses
Stevanovic et al.	2019	Replacement Therapy
KR20030006787A (ko)	2003-01-23	트리칼슘포스페이트를 함유한 골대체제용 키토산 비드
JOSHUA et al.	2002	CNS: Use of Microglia and Biopolymer